Average Co-Inventor Count = 4.02
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ucb Pharma, S.a. (24 from 179 patents)
2. Ucb Biopharma Sprl (5 from 138 patents)
3. Wyeth Holdings Corporation (4 from 113 patents)
4. Biogen Idec Ma Inc. (2 from 216 patents)
5. Biogen Ma Inc. (1 from 250 patents)
6. Ucb Celltech (1 from 1 patent)
7. Celltech Chiroscience Limited (1 from 1 patent)
8. R-pharm International LLC (0 patent)
35 patents:
1. 10308723 - Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F
2. 10017575 - Antibody molecules having specificity for human OX40
3. 9890219 - Methods of treating an IL-17A mediated pathological condition
4. 9631015 - Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6
5. 9428570 - Antibody molecules having specificity for human OX40
6. 9351986 - Calicheamicin derivative-carrier conjugates
7. 9321840 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
8. 9249232 - Framework selection
9. 9096668 - Methods for making antibody molecules having specificity for human IL-6
10. 8865167 - Neutralising antibody molecules having specificity for human IL-17
11. 8835611 - Calicheamicin derivative-carrier conjugates
12. 8784823 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
13. 8747857 - Calicheamicin derivative-carrier conjugates
14. 8617847 - Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F
15. 8614295 - Antibody molecules having specificity for human OX40